Abstract
The Cryptococcus neoformans species complex (CNSC) is a common opportunistic human fungal pathogen and the most frequent cause of fungal meningitis. There are three major serotypes in CNSC: A, D, and their hybrids AD, and they have different geographic distributions and medical significance. Melanin pigment and a polysaccharide capsule are the two major virulence factors in CNSC. However, the relationships between serotype and virulence factor production and how environmental factors might impact their relationships are not known. This study investigated the expressions of melanin and capsular polysaccharide in a genetically diverse group of CNSC strains and how their phenotypic expressions were influenced by oxidative and nitrosative stress levels. We found significant differences in melanin and capsular polysaccharide productions among serotypes and across stress conditions. Under oxidative stress, the laboratory hybrids exhibited the highest phenotypic plasticity for melanin production while serotype A showed the highest for capsular polysaccharide production. In contrast, serotype D exhibited the highest phenotypic plasticity for capsular polysaccharide production and clinical serotype AD the highest phenotypic plasticity for melanin production under nitrosative stress. These results demonstrated that different serotypes have different environmental condition-specific mechanisms to modulate the expression of virulence factors.
Similar content being viewed by others
Data Availability
All data described in the study are presented in the manuscript and as supplementary files.
References
Yamamura D, Xu J. Update on Pulmonary Cryptococcosis. Mycopathologia. 2021;186:717–28
Chen M, Xu N, Xu J. Cryptococcus neoformans meningitis cases among China’s HIV-infected population may have been severely under-reported. Mycopathologia. 2020;185:971–4.
Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7:375–81.
Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun. 2009;77:120–7.
Speed B, Dunt D. Clinical and host differences between infections with the two varieties of cryptococcus neoformans. Clin Infect Dis. 1995;21:28–34.
Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Crypotcoccus neoformans. Clin Microbiol Rev. 1995;8:515–48.
Damasceno-Escoura A, de Souza ML, de Oliveira Nunes F, et al. Epidemiological, clinical and outcome aspects of patients with cryptococcosis caused by cryptococcus gattii from a non-endemic area of Brazil. Mycopathologia. 2019;184:65–71.
García-Rodas R, Zaragoza O. Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans. FEMS Immunol Med Microbiol. 2012;64:147–61.
Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol. 2004;2(10):820–32.
Zaragoza O, Chrisman CJ, Castelli MV, Frases S, Cuenca-Estrella M, Rodríguez-Tudela JL, et al. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol. 2008;10:2043–57.
Nathan CF, Hibbs JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol. 1991;3:65–70.
Naslund PK, Miller WC, Granger DL. Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells. Infect Immun. 1995;63:1298–304.
Lovchik JA, Lyons CR, Lipscomb MF. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am J Respir Cell Mol Biol. 1995;13:116–24.
Tohyama M, Kawakami K, Futenma M, Saito A. Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide. Clin Exp Immunol. 2007;103:436–141.
Lee SC, Kress Y, Zhao ML, Dickson DW, Casadevall A. Cryptococcus neoformans survive and replicate in human microglia. Lab Investig. 1995;73:871–9.
Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after cryptococcus neoformans phagocytosis by macrophages. Curr Biol. 2006;16:2161–5.
Barchiesi F, Cogliati M, Esposto MC, Spreghini E, Schimizzi AM, Wickes BL, et al. Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis. J Infect. 2005;51:10–6.
Irokanulo EAO, Akueshi CO. Virulence of Cryptococcus neoformans serotypes A, B, C and D for four mouse strains. J Med Microbiol. 1995;43:289–93.
Casadevall A, Rosas AL, Nosanchuk JD. Melanin and virulence in cryptococcus neoformans. Curr Opin Microbiol. 2000;3:354–8.
Charlier C, Chrétien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F. Capsule structure changes associated with cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol. 2005;166:421–32.
Jacobson ES, Tinnell SB. Antioxidant function of fungal melanin. J Bacteriol. 1993;175:7102–4.
Emery HS, Shelburne CP, Bowman JP, Fallon PG, Schulz CA, Jacobson ES. Genetic study of oxygen resistance and melanization in Cryptococcus neoformans. Infect Immun. 1994;62:5694–7.
Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun. 1995;63:3131–6.
Liu L, Tewari RP, Williamson PR. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect Immun. 1999;67:6034–9.
Kwon-Chung KJ, Polacheck I, Popkin TJ. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol. 1982;150:1414–21.
Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococccus neoformans. Infect Immun. 1986;51:218–23.
Wang Y, Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun. 1994;62:3004–7.
Kozel TR, Gotschlich EC. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol. 1982;129:1675–80.
Tucker SC, Casadevall A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci (USA). 2002;99:3165–70.
Zaragoza O, Rodrigues ML, De Jesus M, Frases S, Dadachova E, Casadevall A. The Capsule of the Fungal Pathogen Cryptococcus neoformans. Adv Appl Microbiol. 2009;68:133–216.
Bulmer GS, Sans MD, Gunn CM. Cryptococcus neoformans. I Nonencapsulated mutants J Bacteriol. 1967;94:1475–9.
Bulmer GS, Sans MD. Cryptococcus neoformans. II Phagocytosis by human leukocytes. J Bacteriol. 1967;94:1480–3.
Kozel TR, Cazin J. Nonencapsulated variant of cryptococcus neoformans i. virulence studies and characterization of soluble polysaccharide. Infect Immun. 1971;3:287–94.
Stearns SC. The evolutionary significance of phenotypic plasticity. Bioscience. 1989;39:436–45.
Guerrero A, Jain N, Goldman DL, Fries BC. Phenotypic switching in Cryptococcus neoformans. Microbiology. 2006;152:3–9.
Yan Z, Li X, Xu J. Geographic distribution of mating type alleles of Cryptococcus neoformans in four areas of the United States. J Clin Microbiol. 2002;40:965–72.
Samarasinghe H, Aceituno-Caicedo D, Cogliati M, Kwon-Chung KJ, Rickerts V, Velegraki A, et al. Genetic factors and genotype-environment interactions contribute to variation in melanin production in the fungal pathogen cryptococcus neoformans. Sci Rep. 2018;8:9824.
Sun S, Xu J. Chromosomal rearrangements between serotype A and D strains in Cryptococcus neoformans. PLoS ONE. 2009;4:e5524.
Nielsen K, Cox GM, Wang P, Toffaletti DL, Perfect JR, Heitman J. Sexual cycle of Cryptococcus neoformans var. grubii and Virulence of congenic a and α isolates. Infect Immun. 2003;71:4831–41.
Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol. 1993;175:1405–11.
Hua W, Vogan A, Xu J. Genotypic and phenotypic analyses of two “isogenic” strains of the human fungal pathogen cryptococcus neoformans var. neoformans. Mycopathologia. 2019;184:195–212.
Vogan AA, Khankhet J, Xu J. Evidence for Mitotic Recombination within the Basidia of a Hybrid Cross of Cryptococcus neoformans. PLoS ONE. 2013;8:e62790.
Vogan AA, Xu J. Evidence for genetic incompatibilities associated with post-zygotic reproductive isolation in the human fungal pathogen Cryptococcus neoformans. Genome. 2014;57:335–44.
Brandt ME, Hutwagner LC, Klug LA, Baughman WS, Rimland D, Graviss EA, et al. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. J Clin Microbiol. 1996;34:912–7.
Samarasinghe H, Vogan A, Pum N, Xu J. Patterns of allele distribution in a hybrid population of the Cryptococcus neoformans species complex. Mycoses. 2020;63:275–83.
Vogan AA, Khankhet J, Samarasinghe H, Xu J. Identification of QTLs associated with virulence related traits and drug resistance in Cryptococcus neoformans. G3: Genes, Genomes, Genet. 2016;6:2745–59.
Bryan RA, Zaragoza O, Zhang T, Ortiz G, Casadevall A, Dadachova E. Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot Cell. 2005;4:465–75.
Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem. 1956;28:350–6.
Valladares F, Sanchez-Gomez D, Zavala MA. Quantitative estimation of phenotypic plasticity: bridging the gap between the evolutionary concept and its ecological applications. J Ecol. 2006;94:1103–16.
Guerrero A, Jain N, Wang X, Fries BC. Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation. Infect Immun. 2010;78:1049–57.
Fries BC, Goldman DL, Cherniak R, Ju R, Casadevall A. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun. 1999;67:6076–83.
Goldman DL, Fries BC, Franzot SP, Montella L, Casadevall A. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc Natl Acad Sci (USA). 1998;95:14967–72.
Fries BC, Taborda CP, Serfass E, Casadevall A. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest. 2001;108:1639–48.
Littman ML, Tsubura E. Effect of degree of encapsulation upon virulence of cryptococcus neoformans. Exp Biol Med. 1959;101:773–7.
McFadden DC, Fries BC, Wang F, Casadevall A. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot Cell. 2007;6:1464–73.
Sabiiti W, Robertson E, Beale MA, Johnston SA, Brouwer AE, Loyse A, et al. Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J Clin Invest. 2014;124:2000–8.
Robertson EJ, Najjuka G, Rolfes MA, Akampurira A, Jain N, Anantharanjit J, et al. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis. J Infect Dis. 2014;209:74–82.
Xu J, Luo G, Vilgalys R, Brandt ME, Mitchell TG. Multiple origins of hybrid strains of Cryptococcus neoformans with serotype AD. Microbiology. 2002;148:203–12.
Samarasinghe H, You M, Jenkinson TS, Xu J, James TY. Hybridization Facilitates Adaptive Evolution in Two Major Fungal Pathogens. Genes. 2020;11:101.
Dong K, You M, Xu J. Genetic Changes in Experimental Populations of a Hybrid in the Cryptococcus neoformans Species Complex. Pathogens. 2020;9:3.
Polacheck I, Platt Y, Aronovitch J. Catecholamines and virulence of Cryptococcus neoformans. Infect Immun. 1990;58:2919–22.
Alspaugh JA, Granger DL. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun. 1991;59:2291–6.
Xie Q, Kawakami K, Kudeken N, Zhang T, Qureshi MH, Saito A. Different susceptibility of three clinically isolated strains of cryptococcus neoformans to the fungicidal effects of reactive nitrogen and oxygen intermediates: possible relationships with virulence. Microbiol Immunol. 1997;41:725–31.
Cox GM, Harrison TS, McDade HC, Taborda CP, Heinrich G, Casadevall A, et al. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect Immun. 2003;71:173–80.
Akhter S, McDade HC, Gorlach JM, Heinrich G, Cox GM, Perfect JR. Role of alternative oxidase gene in pathogenesis of Cryptococcus neoformans. Infect Immun. 2003;71:5794–802.
Acknowledgements
We thank Dr. Max Cogliati, Dr. Volker Rickerts, Dr. Tracey Moore, and Himeshi Samarasinghe for strains. This study was supported by grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada and by the Institute of Infectious Diseases Research at McMaster University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
We confirm that all methods in this study were carried out in accordance with relevant guidelines and regulations. In addition, all experimental protocols were approved by McMaster University. No human nor animal was used as subject in this research.
Additional information
Handling Editor: Min Chen.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Iyengar, Y., Xu, J. Phenotypic Plasticity in the Productions of Virulence Factors Within and Among Serotypes in the Cryptococcus neoformans Species Complex. Mycopathologia 187, 65–83 (2022). https://doi.org/10.1007/s11046-021-00597-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-021-00597-3